Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for April 2010
April 1, 2010
- IMS Health Reports U.S. Prescription Sales Grew 5.1 Percent in 2009, to $300.3 Billion
- Teva Settles Generic Eloxatin Litigation
- K-V Pharmaceutical Announces Reduction in Force
- Sanofi-aventis Announces Settlement of Eloxatin U.S. Patent Litigation
- Federal Judge Upholds Patent Protecting Lilly Drug
April 2, 2010
- Ex-Pfizer Scientist Wins $1.37 Million in Federal Lawsuit
- Jury Awards Ex-Pfizer Scientist $1.37 Million
- Teva Receives Favorable Court Decision Regarding Seasonique
- Avodart May Promote Some Tumor Growth
- Federal Judge Upholds Patent Protecting Lilly Drug
- China Ups Monitoring After Recall Of Vaccine
April 5, 2010
- Repros Requests Lift of Clinical Hold on Proellex
- Warner Chilcott Announces Amendment to Actonel Collaboration Agreement with sanofi-aventis
- Simcere Says Rabies Shot Lacked Active ingredient
- Boston Herald Editorial: Dose of Good Sense
- FAA Proposes New Policy on Antidepressants for Pilots
April 6, 2010
- FDA Notes Suicides With Forest, Nycomed COPD Drug Daxas
- Poisoning By Prescription Drugs On The Rise
- Crucell And Glaxo Will Combine Malaria vaccines
- Genentech Opens $400 Million Manufacturing Center
- Sanofi-Aventis Settles Generic Eloxatin suits
April 7, 2010
- Novartis Gender Discrimination Trial Begins Today
- Publicis Healthcare Communications Group acquires In-Sync Customer Insights
- Cancer Vaccines May Be On The Verge Of Wider Use
- Shire Receives Second Intuniv Paragraph IV Notice Letter
- Ambrilia Biopharma Provides Update on Its Restructuring Efforts
- Controversial Flu Vaccine Study Finally Published, but Questions Raised Linger
- Allon Therapeutics announces davunetide receives FDA Fast Track Status for treatment of Progressive Supranuclear Palsy
April 8, 2010
- Labopharm completes licensing and distribution agreement with Nippon Shinyaku for once-daily tramadol in Japan
- Valeant Looks at Durham, N.C. Location
- Micurx, Cumencor Sign Development Deal With Pfizer
- FDA Sends Letter to Aton Pharma Over Flash Card
- CureDM Partners Novel Diabetes Treatment with Sanofi-Aventis
- New Arrhythmia Drug Modestly Effective
- Montana Governor Has New Idea For Cheaper Drugs: The VA
- FDA Sends Letter to Gilead Over Truvada Ad
- FDA Sends Letter to Biogen Idec Over Tysabri Webcast
- Bristol-Myers Squibb Board Elects Charles Bancroft Chief Financial Officer
April 9, 2010
- Sanofi-Aventis, CureDM Developing Diabetes Drug
- Ex-Wyeth CEO Joins Carlyle Group As Senior Adviser
- Pfizer Continues Next Round Of Layoffs: 25 Employees Expected to be Cut Today
- Lawyer For Female Novartis Workers Says They Are Cheated But Company Denies Claim in NYC Trial
- Forest Laboratories Shares Fall After Panel Vote
- Cephalon Finishes Acquisition of Mepha
April 12, 2010
- Basilea Pharmaceutica AG (CH) - Discontinuation of Sale of ceftobiprole in Canada
- FDA Reviewer Says Byetta May Pose Cancer Risk
- Merck KGaA Annual General Meeting: Shareholders Approve Dividend of ? 1.00 per Share
- Lilly is Downsizing its Downtown Footprint: Employees Returning to Headquarters as Company Exits $100 Million Office Park
- Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
April 13, 2010
- Gilead Starts Late Stage Tests of 4-In-1- HIV Drug
- J&J Unit To Stop Selling Skin Treatment In Canada
- Teva, Baxter Sued in Hepatitis C Outbreak Case
- Palm Beach Drug Maker Takes On Overseas Competitors
- Sanofi-Aventis, US Navy In Diarrhea vaccine pact
- Mersana Enters Research and Exclusive License Agreement with Teva Pharmaceuticals for the Development and Commercialization of XMT-1107
- Icagen Eyes Investors, Buyers As It Trawls for Cash
- Molecular Insight Stock Soars
April 14, 2010
- Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
- Arbor Pharmaceuticals Is Sold
- Aveo Receives $5 Million Payment From Biogen
- French Novagali In Takeover Talks, Considers Going Public
- Report: Baxter Alzheimer's Treatment Working
- Pozen, Teva Settle Patent Dispute Over Treximet
- California Eyes Prohibiting Sale of MD Prescription Habits
- Endo And Penwest Settle Opana ER Patent Lawsuit
- Teva Pays $334M to Collaborate On Cancer Drug
- FDA Warns Apotex Over Manufacturing Facility Conditions
- FDA Warns Slate Over Testopel sales aid
- Use Of Certain Anticonvulsant Medications May Be Associated With Increased Risk Of Suicide
April 15, 2010
- Lorus Therapeutics Says It Needs New Investment Cash As It Reports a Q3 Loss
- Former Executive Of J&J Subsidiary Jailed
- VA Shoots Down Montana Gov's Plan For Cheap Drugs
- XOMA Receives $1 Million Milestone Payment From Takeda Pharmaceutical
- Ralph Whitworth Elected to Genzyme's Board of Directors
- Excellent growth in first quarter of 2010
- Immunogen Shares Rise On Breast Cancer Drug Plans
April 16, 2010
- Impax Labs Now Co-Promoting Pfizer's Lyrica
- Phase Forward Agrees to Be Acquired by Oracle
- Charlotte Region's Prospects For Drug Firms Mixed
- Impax Labs Now Co-Promoting Pfizer's Lyrica
- Pfizer Enters Reagent Partnership With Stemgent
- Cell Therapeutics Cuts 28 Percent Of Staff
- Perrigo Begins Selling Generic Analpram HC Cream
- Aeterna Zentaris Stock Rises After Study Reviewed
- Trial Drug Vastly Boosts Hepatitis C Cure
April 18, 2010
April 19, 2010
- FDA Sends GSK Letter over Arzerra Journal Ad
- Novartis International AG (CH) - Sandoz to acquire Oriel Therapeutics, gaining rights to portfolio of respiratory products targeting asthma and COPD
- Lilly Reports First-Quarter 2010 Results
- Elan Announces Exploration Of EDT Separation And Board Changes
- Elan Considers Split, Chairman Retiring
- Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders
- Alimera Sciences Expects IPO To Raise about $87M
- Hospira Recalls Propofol, Liposyn Due to Contamination
- Human Genome Partner Pulls European drug filing
- Earnings Preview: J&J Sales Growth Key To Rebound
- Array BioPharma Signs Strategic Oncology Collaboration
April 20, 2010
- Novartis Healthcare Portfolio Generates Strong Growth in First Quarter of 2010, Progress on Delivering Innovation, Growth and Productivity
- IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014; Maintains Expectations of 4-6% Growth in 2010
- Biogen Idec Reports First Quarter 2010 Results Tysabri Revenues Increase 32% Year over Year
- Boehringer Ingelheim grows faster than the pharmaceutical market for the tenth time in succession/continued high level of investment in R&D/market launch of five innovative medicines planned
- Gilead Terminates Phase II Clinical Trial of GS 9450 in Patients With Chronic Hepatitis C
- HCV research agreement with Boehringer Ingelheim concludes
- Lannett Gets FDA Approval For Generic Zofran
- Enzyme Maker Codexis Plans To Go Public this week
- Mylan Now Selling Generic Antipsychotic Clozaril
- Swiss Drug Maker Novartis Says 1Q Net profit up 49 pct to $2.95B as Flu Vaccine Boosts Sales
- Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2010 Earnings Per Share of $0.07, Including a One-Time Charge Totaling $0.76 Per Share
- Johnson & Johnson Reports 2010 First-Quarter Results
- As FDA Guideline Calls For More Secure Pharmaceutical Supply Chain, COVECTRA Offers Robust Solutions
- Seattle Genetics Gets $9.5M Payment From Roche
April 21, 2010
- Hpv Vaccine Kills 16-Year-Old Girl Lawsuit Alleges
- Gilead Sciences Announces Record First Quarter 2010 Financial Results
- Abbott Reports Strong First Quarter Results; Forecasts Double-Digit Ongoing Earnings Growth in 2010
- Silence Therapeutics and AstraZeneca Extend siRNA Delivery Collaboration
- Gilead Sciences 1Q Profit Jumps, But outlook Cut
- FDA Warns Pfizer Over Clinical Trials of Unnamed Drug
- Drug Companies Agree to $7.75 Million Settlement With State
- Dr. Jörg Reinhardt appointed new CEO of Bayer HealthCare
- Genzyme Reports Financial Results for the First Quarter of 2010
- Express Scripts Cites Waste In Spending
- FDA Announces Draft Revised Guidance on Transparency and Advisory Committees
- Abbott Completes Acquisition of Facet Biotech
April 22, 2010
- FDA Announces Draft Revised Guidance on Transparency and Advisory Committees
- FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil
- Drugmaker Elan Posts Narrower Loss In 1st Quarter
- Genzyme Books First Quarter Loss on Government Manufacturing Fine
- ND Senator, Mont. Gov Seek Drug Import Exemption
- Ed Silverman and Pharmalot Join Forces With Med Ad News and PharmaLive
- Pharma Opposes Bill to Limit Perks for Doctors
April 23, 2010
- Med Ad News Honors Healthcare Advertisers at 21st Annual Manny Awards
- Pfizer Ends Trial of Sutent in Liver Cancer
- PharmaLive Releases Annual ?Account Rosters: Healthcare Communications Agencies? Special Report
- Amylin, Partners Respond to FDA's Bydureon Request
- Pfizer Shareholders Reject Activist's Proposed Ban on Exec Stock Options, Back Advisory Vote
- Amgen's First Quarter 2010 Adjusted Earnings Per Share Increased 20 Percent to $1.30
April 26, 2010
- FDA Sends Letter to Adolor Regarding Statement About Entereg
- Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas in Europe and Canada
- FDA Sends Letter to Sanofi-Aventis Regarding Eligard Promotion
- Charles River Laboratories and WuXi PharmaTech to Combine, Creating the First Global CRO Offering Fully Integrated Early-Stage Drug Development Services to Clients Worldwide
- Pharmalive?s New ?Investigational Drug Review And Outlook? Special Report Analyzes Compounds In Development That Show Promise For Unmet Medical Need
- Arrowhead Announces the Appointment of Former FDA Commissioner and National Cancer Institute Director Dr. Andrew von Eschenbach to Its Board of Advisors
- Watson Says Court Affirms ADHD Drug Patent Ruling
- Amgen Appoints Robert A. Bradway President and Chief Operating Officer
- Amgen Appoints Robert A. Bradway President and Chief Operating Officer
April 27, 2010
- Patients, Clinicians Favor Disclosure of Financial Ties to Industry
- Alcon 1Q Profit Rises 27 Percent On Sales Boost
- Hospira Profit Down As Tax Benefit Comes Off Books
- U.S. Supreme Court Affirms Lower Court Decision on Merck Federal Securities Class Action
- EU Panel Votes To Crack Down On Illegal Medicines
- Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
April 28, 2010
- Drug-Laser Combination Proves Effective For Diabetic Blindness
- US Official: Astrazeneca To Pay $520 Million
- Largest Civil Settlement in Pharmaceutical Case Announced by U.S. Department of Justice
- GSK announces Q1 results for 2010
- Astellas Pharma US, Inc. Announces Construction of New Corporate Headquarters
- Alcon Independent Director Committee Notes that Novartis' Grossly Inadequate Merger Proposal Continues to Deteriorate Even in the Face of Alcon's Strong Earnings
- GlaxoSmithKline Says Q1 Profit Up 19%
- Alzheimer's Research Wins Award For Pfizer
- Mylan Starts Shipping Generic Version Of Flomax
- PPD Opens Vaccine Study Center In China
- Germany planing to freeze drug prices
- Public Citizen Wants Avandia Study Halted
- FDA Urges Industry To Take Anti-Theft Steps
- FDA Warns Teva On California Plant
April 29, 2010
- Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter
- Brazil Court Rules Viagra Patent Ends In June
- Sanofi-Aventis 1st Quarter Profit Up 8.6 Percent
- Brazil Court Rules Viagra Patent Ends In June
- Watson Confirms Rapamune Patent Challenge
- Shire's Replenished Portfolio Drives Excellent Quarterly Performance
- Mylan Reports Adjusted Diluted EPS of $0.36 for the Quarter Ended March 31, 2010
- Interim report for the first quarter of 2010: Bayer achieves strong gains in sales and earnings
- Q1 2010: A Good First Quarter
- Merck Announces Senior Management Appointments
- AstraZeneca PLC First Quarter Results 2010
- FDA Urges Industry to Take Additional Steps to Prevent Cargo Theft
- Novavax Says Flu Shot Is Safe For The Elderly
- Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past Topamax Marketing and Promotional Activities
April 30, 2010
- US: 2 Drug Subsidiaries Agree To Settle On Topamax
- Allergan Reports First Quarter 2010 Operating Results
- Change in Sanofi-Aventis Executive Committee
- Pozen Eager For Drug Approval
- Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex
- Pharmalive.com And Med Ad News Launch Community Pharm
- Neurogesx Enters $40 M Royalty Financing Agreement
